-
adverse effect
general term for undesirable and potentially harmful drug effect.
-
agonist
drug that binds to a receptor and activates a physiologic response or drug action
-
antagonist
drug that binds to a receptor and interferes with other drugs or substances from producing a drug effect
-
chemical name
name that defines the chemical composition of a drug
-
contraindications
situations or conditions when a certain drug should not be administered
-
controlled substance
drug that has the potential for abuse and thus is regulated by law
-
dose
a measurement of the amount of drug that is administered
-
drug
chemical substance that produces a change in body function
-
drug indications
intended or indcated uses for any drug
-
ED50 effective dose 50
dose that will produce an effect that is half of the maximal response
-
generic name
nonproprietary name of the drug
-
LD50
letahl dose 50, or dose that will kill 50 percent of the laboratory animals tested.
-
mechanism of action
explanation of how a drug produces its effects.
-
nonprescription, over-the-counter (OTC) drug
drug that can be purcharsed without the services of a physician
-
pharmacology
study of drugs
-
potency
measure of the strength, or concencentration , of a drug required to produce a specific effect
-
prescription drug
drug for which dispensiing requires a written or phone order that can be issued by or under the direction of a licensed physician
-
receptor
specific cellular structure that a drug binds to and that produces a physiologic effect
-
side effect
drug effect other than the therapeutic effect that is usually undesirable but not harmful
-
site of action
location within the body where a drug exerts its therapeutic effect, often a specific drug receptor
-
therapeutic effect
desired drug effect to alleviate some condition or symptom of disease
-
therapeutic index (TI)
ratio of the LD50 to the ED50 in animal studies
-
toxic effect
undesirable drug effect that implies drug poisoning; can be harmful or life-threatening
-
trade name
patented proprietary name of a drug sold by a specific drug manufacturer; also referred to as the brand name
-
bioavailability
percentage of drug dosage that is absorbed
-
drug absorption
entrance of a drug into the bloodstream from its site of administration
-
drug addiction
condition of drug abuse and drug dependence that is characterized by compulsive drug behavior
-
drug dependence
condition of reliance on the use of a particular drug, characterized as physical and/or psychological dependence
-
drug distribution
passage of a drug from the blood to teh tissues and organs of the body
-
drug excretion
elimination of the drug from the body
-
drug metabolism
the enzymatic biotransformation of a drug into metabolites
-
drug microsomal metabolizing system (DMMS)
group of enzymes located primarily in the liver that function to metabolize (biotransformation) drugs
-
drug tolerance
decreased drug effect occurring after repeated drug administration
-
enzyme induction
increase in the amount of drug-metabolizing enzymes after repeated administration of certain drugs
-
enzyme inhibition
inhibition of drug-metabolizing enzymes by certain drugs
-
first pass metabolism
drug metabolism that occurs in the intestines and liver during oral absorption of drugs into the systemic circulation
-
half-life
time required for the body to reduce the amount of drug in the plasma by one-half
-
individual variation
difference in the effects of drugs and drug dosages from one person to another
-
intramuscular (IM) injection
route of drug administration; drug is injected into gluteal or deltoid muscles
-
intravenous (IV) injection
route of drug administration; drug is injected directly into a vein
-
loading dose
initial drug dose administered to rapidly achieve therapeutic drug concentrations
-
maintenance dose
dose administered to maintain drug blood levels in the therapeutic range
-
oral administration
route of drug administration by way of the mouth through swallowing
-
parenteral administration
route of drug administration that does not involve the gastrointestinal (GI) tract
-
pharmacokinetics
describes the processes of drug absorption, drug distribution, drug metabolism, and drug excretion
-
acetylcholine (AcHG)
neurotransmitter of parasympathetic (cholinergic) nerves; stimulates the cholinergic receptor
-
adrenergic receptor
receptor located on internal organs that responds to norepinephrine and epinephrine
-
afferent nerve
transmits sensory information from peripheral organs to the brain and spinal cord (central nervous system)
-
autonomic nervous system (ANS)
system of nerves that innervate smooth and cardiac muscle (involuntary) of the internal organs and glands
-
cholinergic (muscarinic) receptor
receptor located on internal organs and glands that responds to acetylcholine
-
efferent nerve
carries the appropriate motor response from the brain and spinal cord to the peripheral organs
-
epinephrine (EPI)
hormone from adrenal medulla that stimulates adrenergic receptors, especially during stress
-
fight or flight reaction
response of the body to intense stress; caused by activation of the sympathetic division of the ANS
-
homeostasis
normal state of balance among the body's internal organs
-
neurotransmitter
substance that stimulates internal organs to produce characteristic changes associated with sympathetic and parasympathetic divisions
-
norepinephrine (NE)
neurotransmitter of sympathetic (adrenergic) nerves that stimulates the adrenergic receptors
-
parasympathetic
refers to nerves of the ANS that originate in the brain and sacral portion of the spinal cord; they are active when the body is at rest or trying to restore body energy and function
-
sympathetic
refers to nerves of the ANS that originate form the thorocolumbar portion of the spinal cord; they are active when the body is under stress or when it is exerting energy
-
adrenergic neuronal blocker
drug that acts at the neuronal nerve endings to reduce the formation or release of NE
-
alpha-adrenergic drug
drug that stimulates the alpha adrenergic receptors
-
alpha-1 adrenergic blocker
drug that blocks the alpha-1 effects of NE and EPI
-
alpha-1 adrenergic receptor
receptor located on smooth muscle that reduces the release of NE
-
beta-1 adrenergic receptor
receptor located on the heart that increases heart rate and force of contraction
-
beta-2 adrenergic receptor
receptor located on smooth muscle that relaxes smooth muscle when stimulated
-
catecholamine
refers to norepinephrine, epinephrine, and other sympathomimetic compounds that possess the catechol structure
-
false transmitter
substance formed in nerve endings that mimics and interferes with the action of the normal neurotransmitter
-
nonselective beta-adrenergic blocker
drug that blocks both beta-1 and beta-2 receptors
-
nonselective beta-adrenergic drug
drug that stimulates both beta-1 and beta-2 receptors
-
selective beta-1 adrenergic blocker
drug that blocks only beta-1 receptors
-
selective beta-2 adrenergic drug
drug that stimulates only beta 2 receptors at therapeutic doses
-
sympatholytics
refers to the action of an adrenergic blocking drug or an action that decreases sympathetic activity
-
sympathomimetic
refers to the action of an adrenergic drug or an action that increases sympathetic activity
-
acteylcholinesterase
an enzyme that inactivates acteylcholine
-
anticholinergic
refers to drugs or effects that reduce the activity of the parasympathetic nervous system
-
cholinergic
refers to the nerves and receptors of the parasympathetic nervous system; also refers to the drugs that stimulate this system
-
muscarinic receptor
an older but more specific term for the cholinergic receptor on smooth and cardiac muscle
-
nicotinic-muscle (Nm) receptor
cholinergic receptor located at the neuromuscular junction of skeletal muscle
-
nicotinic-neural (Nn) receptor
cholinergic receptor located on both sympathetic and parasympathetic nervous system
-
parasympatholytics
refers to drugs (anticholinergic) that decreases activity of the parasympathetic nervous system
-
parasympathomimetic
refers to drugs (cholinergic) that mimic stimulation of the parasympathetic nervous system
|
|